Home LiteratureArticle Details
PMID: 21159946 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Review

Reimagining Alzheimer's disease--an age-based hypothesis.

Herrup K

Abstract

The historical roots of Alzheimer's disease provide a sound conceptual basis for linking the behavioral and neurological symptoms of the disease with the frequently associated pathology of amyloid plaques and neurofibrillary tangles. Out of these roots has grown the "amyloid cascade hypothesis"--a vision of the etiology of Alzheimer's that has spurred the discovery of many important insights into the neurobiology of the disease. Despite these successes, the wealth of new data now available to biomedical researchers urges a full review of the origins of Alzheimer's, and such a reconsideration is offered here. It begins with the most widely accepted risk factor for developing Alzheimer's disease: age. Then, for an individual to progress from normal age-appropriate cognitive function to a condition where the full palette of clinical symptoms is expressed, three key steps are envisioned: (1) an initiating injury, (2) a chronic neuroinflammatory response, and (3) a discontinuous cellular change of state involving most, if not all, of the cell types of the brain. The amyloid cascade is integrated into this sequence, but reconfigured as an amyloid deposition cycle. In this way, the pathology of amyloid plaques is envisioned as highly correlated with, but mechanistically distinct from, the three obligatory steps leading to Alzheimer's disease. The implications of this new model are discussed with respect to our current diagnostic criteria, and suggestions are put forward for expanding our future research efforts.

MeSH Terms
Age Factors Alzheimer Disease/etiology,metabolism,pathology Amyloid/metabolism Brain/metabolism,pathology Humans Models, Neurological Plaque, Amyloid/metabolism
Chemicals
Amyloid
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Herrup Karl
Department of Cell Biology and Neuroscience, Rutgers University, Piscataway, New Jersey 08854, USA. herrup@biology.rutgers.edu
References (76)
76 references, click to expand
  1. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.
    Ann Neurol. 1991 Oct;30(4):572-80 PMID: 1789684
  2. Alzheimer's disease is a synaptic failure.
    Science. 2002 Oct 25;298(5594):789-91 PMID: 12399581
  3. Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms.
    J Neurosci. 2005 Jun 1;25(22):5446-54 PMID: 15930395
  4. Selective cell death of hyperploid neurons in Alzheimer's disease.
    Am J Pathol. 2010 Jul;177(1):15-20 PMID: 20472889
  5. Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease.
    J Neurosci. 1996 Jan;16(1):186-99 PMID: 8613784
  6. Activated astroglia during chronic inflammation in Alzheimer's disease--do they neglect their neurosupportive roles?
    Mutat Res. 2010 Aug 7;690(1-2):40-9 PMID: 19748514
  7. Beta-amyloid activated microglia induce cell cycling and cell death in cultured cortical neurons.
    Neurobiol Aging. 2000 Nov-Dec;21(6):797-806 PMID: 11124423
  8. Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation.
    J Neurosci. 2010 Feb 17;30(7):2636-49 PMID: 20164348
  9. NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease.
    J Clin Invest. 2009 Dec;119(12):3692-702 PMID: 19907078
  10. Tau is a candidate gene for chromosome 17 frontotemporal dementia.
    Ann Neurol. 1998 Jun;43(6):815-25 PMID: 9629852
  11. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord.
    J Neurosci. 2009 Oct 28;29(43):13435-44 PMID: 19864556
  12. Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis.
    Ann Neurol. 2005 Dec;58(6):939-45 PMID: 16315280
  13. Synaptic loss in Alzheimer's disease and other dementias.
    Neurology. 1989 Mar;39(3):355-61 PMID: 2927643
  14. Inflammation and Alzheimer's disease.
    Neurobiol Aging. 2000 May-Jun;21(3):383-421 PMID: 10858586
  15. Strategies for disease modification in Alzheimer's disease.
    Nat Rev Neurosci. 2004 Sep;5(9):677-85 PMID: 15322526
  16. Abeta oligomers induce neuronal cell cycle events in Alzheimer's disease.
    J Neurosci. 2008 Oct 22;28(43):10786-93 PMID: 18945886
  17. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease.
    Ann Neurol. 1997 Jan;41(1):17-24 PMID: 9005861
  18. Neuronal changes in normal human aging and Alzheimer's disease.
    Brain Cogn. 2002 Aug;49(3):268-76 PMID: 12139954
  19. Protective effects of NSAIDs on the development of Alzheimer disease.
    Neurology. 2008 May 6;70(19):1672-7 PMID: 18458226
  20. Inflammation, microglia, and Alzheimer's disease.
    Neurobiol Dis. 2010 Mar;37(3):503-9 PMID: 19833208
  21. Inflammation in Alzheimer disease: driving force, bystander or beneficial response?
    Nat Med. 2006 Sep;12(9):1005-15 PMID: 16960575
  22. Oxidized lipoproteins increase reactive oxygen species formation in microglia and astrocyte cell lines.
    Brain Res. 1999 May 29;830(1):10-5 PMID: 10350554
  23. Risk of Alzheimer's disease and duration of NSAID use.
    Neurology. 1997 Mar;48(3):626-32 PMID: 9065537
  24. Inflammation in Parkinson's disease.
    Adv Neurol. 2001;86:83-9 PMID: 11554012
  25. Epilepsy and cognitive impairments in Alzheimer disease.
    Arch Neurol. 2009 Apr;66(4):435-40 PMID: 19204149
  26. Mechanisms underlying inflammation in neurodegeneration.
    Cell. 2010 Mar 19;140(6):918-34 PMID: 20303880
  27. Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease.
    Ann Neurol. 2002 Feb;51(2):182-9 PMID: 11835374
  28. Aneuploid neurons are functionally active and integrated into brain circuitry.
    Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6143-7 PMID: 15837924
  29. Alzheimer's disease and aging: effects on perforant pathway perikarya and synapses.
    Neurobiol Aging. 1992 May-Jun;13(3):405-11 PMID: 1625770
  30. Microglia in ALS: the good, the bad, and the resting.
    J Neuroimmune Pharmacol. 2009 Dec;4(4):389-98 PMID: 19731042
  31. Astroglial expression of human alpha(1)-antichymotrypsin enhances alzheimer-like pathology in amyloid protein precursor transgenic mice.
    Am J Pathol. 2000 Dec;157(6):2003-10 PMID: 11106573
  32. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR.
    Neurosci Lett. 1987 Aug 18;79(1-2):195-200 PMID: 3670729
  33. Astroglia in dementia and Alzheimer's disease.
    Cell Death Differ. 2009 Mar;16(3):378-85 PMID: 19057621
  34. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior.
    Behav Brain Res. 2008 Sep 1;192(1):106-13 PMID: 18359102
  35. Ectopic cell cycle events link human Alzheimer's disease and amyloid precursor protein transgenic mouse models.
    J Neurosci. 2006 Jan 18;26(3):775-84 PMID: 16421297
  36. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD.
    J Neuroinflammation. 2006 Sep 27;3:27 PMID: 17005052
  37. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
    Science. 2002 Jul 19;297(5580):353-6 PMID: 12130773
  38. Involvement of the cerebral cortex in Parkinson disease linked with G2019S LRRK2 mutation without cognitive impairment.
    Acta Neuropathol. 2010 Aug;120(2):155-67 PMID: 20232069
  39. Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease.
    Am J Pathol. 2001 Apr;158(4):1345-54 PMID: 11290552
  40. Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases.
    Hum Mol Genet. 2009 Oct 15;18(R2):R169-76 PMID: 19808793
  41. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier.
    J Clin Invest. 2000 Dec;106(12):1489-99 PMID: 11120756
  42. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.
    Nat Med. 2008 Aug;14(8):837-42 PMID: 18568035
  43. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.
    Neuron. 2007 Sep 6;55(5):697-711 PMID: 17785178
  44. Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications.
    Trends Pharmacol Sci. 2008 Dec;29(12):626-32 PMID: 18835047
  45. The N141I mutation in PSEN2: implications for the quintessential case of Alzheimer disease.
    Arch Neurol. 2010 May;67(5):631-3 PMID: 20457965
  46. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance.
    Immunol Rev. 2008 Apr;222:155-61 PMID: 18364000
  47. Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease.
    J Neurosci. 2003 Apr 1;23(7):2557-63 PMID: 12684440
  48. Mitotic mechanisms in Alzheimer's disease?
    J Cell Biol. 1996 Feb;132(3):413-25 PMID: 8636218
  49. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L).
    J Neurosci. 2005 Nov 16;25(46):10637-47 PMID: 16291936
  50. Inflammation, apoptosis, and Alzheimer's disease.
    Neuroscientist. 2002 Jun;8(3):276-83 PMID: 12061507
  51. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.
    Biochem Biophys Res Commun. 1984 May 16;120(3):885-90 PMID: 6375662
  52. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks.
    Nat Neurosci. 2010 Jul;13(7):812-8 PMID: 20581818
  53. Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression.
    Brain Pathol. 1998 Jan;8(1):65-72 PMID: 9458167
  54. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies.
    Neurology. 1996 Aug;47(2):425-32 PMID: 8757015
  55. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond.
    J Cell Biol. 2009 Dec 14;187(6):761-72 PMID: 19951898
  56. The origin and application of experimental autoimmune encephalomyelitis.
    Nat Rev Immunol. 2007 Nov;7(11):904-12 PMID: 17917672
  57. Autophagy, amyloidogenesis and Alzheimer disease.
    J Cell Sci. 2007 Dec 1;120(Pt 23):4081-91 PMID: 18032783
  58. Inflammation and neurodegenerative diseases.
    Am J Clin Nutr. 2006 Feb;83(2):470S-474S PMID: 16470015
  59. DNA replication precedes neuronal cell death in Alzheimer's disease.
    J Neurosci. 2001 Apr 15;21(8):2661-8 PMID: 11306619
  60. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease.
    Neuroreport. 1996 Nov 25;7(18):3047-9 PMID: 9116237
  61. The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice.
    Neurobiol Aging. 2001 Jan-Feb;22(1):49-61 PMID: 11164276
  62. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain.
    J Neurosci. 1998 Apr 15;18(8):2801-7 PMID: 9525997
  63. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain.
    J Clin Invest. 2008 Dec;118(12):4002-13 PMID: 19033669
  64. The cell division cycle and the pathophysiology of Alzheimer's disease.
    Neuroscience. 1998 Dec;87(4):731-9 PMID: 9759963
  65. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17.
    Nature. 1998 Jun 18;393(6686):702-5 PMID: 9641683
  66. Effect of endothelial cell polarity on beta-amyloid-induced migration of monocytes across normal and AD endothelium.
    Am J Physiol Cell Physiol. 2002 Sep;283(3):C895-904 PMID: 12176746
  67. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.
    Am J Pathol. 1997 Jun;150(6):1933-9 PMID: 9176387
  68. Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake.
    Neuron. 2009 Jun 25;62(6):788-801 PMID: 19555648
  69. Inflammatory process in Parkinson's disease: role for cytokines.
    Curr Pharm Des. 2005;11(8):999-1016 PMID: 15777250
  70. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain.
    J Neurosci. 1997 May 15;17(10):3588-98 PMID: 9133382
  71. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function.
    Arch Neurol. 2004 Mar;61(3):378-84 PMID: 15023815
  72. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations.
    Cell. 2010 Jun 25;141(7):1146-58 PMID: 20541250
  73. Synaptic degeneration in Alzheimer's disease.
    Acta Neuropathol. 2009 Jul;118(1):167-79 PMID: 19390859
  74. Aneuploidy and DNA replication in the normal human brain and Alzheimer's disease.
    J Neurosci. 2007 Jun 27;27(26):6859-67 PMID: 17596434
  75. Inflammatory processes in Alzheimer's disease.
    J Neuroimmunol. 2007 Mar;184(1-2):69-91 PMID: 17222916
  76. Inflammation in neurodegenerative disease--a double-edged sword.
    Neuron. 2002 Aug 1;35(3):419-32 PMID: 12165466
Article Info
Journal
The Journal of neuroscience : the official journal of the Society for Neuroscience
Abbr.
J Neurosci
ISSN
1529-2401
Published
2010-12-15
Pages
16755-62
Language
English
Region
United States
NLM ID
8102140
PMCID
PMC3004746
Subset
IM
Grants
NINDS NIH HHS · R01 NS020591 · United States
NIA NIH HHS · AG029449 · United States
NIA NIH HHS · R01 AG024494-05 · United States
NIA NIH HHS · R01 AG024494 · United States
NINDS NIH HHS · NS20591 · United States
NINDS NIH HHS · R01 NS020591-27 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com